These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32117705)

  • 1. Oncogenic Role of PVT1 and Therapeutic Implications.
    Onagoruwa OT; Pal G; Ochu C; Ogunwobi OO
    Front Oncol; 2020; 10():17. PubMed ID: 32117705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities.
    Hakami MA; Hazazi A; Khan FR; Abdulaziz O; Alshaghdali K; Abalkhail A; Nassar SA; Omar BIA; Almarshadi F; Gupta G; Binshaya AS
    Pathol Res Pract; 2024 Jan; 253():155019. PubMed ID: 38091883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.
    Zhou DD; Liu XF; Lu CW; Pant OP; Liu XD
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 29027279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (
    Wu F; Zhu Y; Zhou C; Gui W; Li H; Lin X
    Genes Dis; 2023 May; 10(3):901-914. PubMed ID: 37396533
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Martínez-Barriocanal Á; Arango D; Dopeso H
    Front Oncol; 2020; 10():38. PubMed ID: 32083000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
    Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
    PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment.
    Li MY; Tang XH; Fu Y; Wang TJ; Zhu JM
    Front Oncol; 2019; 9():787. PubMed ID: 31497532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.
    Li H; Chen S; Liu J; Guo X; Xiang X; Dong T; Ran P; Li Q; Zhu B; Zhang X; Wang D; Xiao C; Zheng S
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2350-2355. PubMed ID: 29277611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PVT1 Signaling Is a Mediator of Cancer Progression.
    Derderian C; Orunmuyi AT; Olapade-Olaopa EO; Ogunwobi OO
    Front Oncol; 2019; 9():502. PubMed ID: 31249809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression.
    Yang T; Zhou H; Liu P; Yan L; Yao W; Chen K; Zeng J; Li H; Hu J; Xu H; Ye Z
    Oncotarget; 2017 Oct; 8(49):85353-85367. PubMed ID: 29156724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PVT1: a Novel Therapeutic Target for Cancers.
    Pan X; Zheng G; Gao C
    Clin Lab; 2018 May; 64(5):655-662. PubMed ID: 29739059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression.
    Guo K; Yao J; Yu Q; Li Z; Huang H; Cheng J; Wang Z; Zhu Y
    Tumour Biol; 2017 Apr; 39(4):1010428317699122. PubMed ID: 28381186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PVT1 and cancer.
    Cui M; You L; Ren X; Zhao W; Liao Q; Zhao Y
    Biochem Biophys Res Commun; 2016 Feb; 471(1):10-4. PubMed ID: 26850852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PVT1 Promotes Cancer Progression via MicroRNAs.
    Wang W; Zhou R; Wu Y; Liu Y; Su W; Xiong W; Zeng Z
    Front Oncol; 2019; 9():609. PubMed ID: 31380270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression.
    Zhang Y; Tan Y; Wang H; Xu M; Xu L
    Med Sci Monit; 2019 Oct; 25():7652-7659. PubMed ID: 31604907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma.
    Posa I; Carvalho S; Tavares J; Grosso AR
    Oncotarget; 2016 Jul; 7(30):47033-47041. PubMed ID: 27366943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA PVT1 induces apoptosis and cell cycle arrest in clear cell renal cell carcinoma through the epidermal growth factor receptor pathway.
    Li W; Zheng Z; Chen H; Cai Y; Xie W
    Oncol Lett; 2018 May; 15(5):7855-7863. PubMed ID: 29725475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.